Medical University of South Carolina Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 104
• Cannabis and Cannabinoid Research 66
• Blood properties and coagulation 65
• Lymphoma Diagnosis and Treatment 60
• Acute Myeloid Leukemia Research 59
• Cancer Immunotherapy and Biomarkers 55
• Lung Cancer Treatments and Mutations 54
• Pancreatic and Hepatic Oncology Research 54
• Smoking Behavior and Cessation 53
• CAR-T cell therapy research 49
• Renal cell carcinoma treatment 44
• Health Systems, Economic Evaluations, Quality of Life 39

Most cited

1. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

   JAMA oncology · 2023 · 399 citations · Scott Lindhorst

2. Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.

   The New England journal of medicine · 2024 · 205 citations · Brian Hess

3. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions.

   CA: a cancer journal for clinicians · 2021 · 430 citations · Benjamin Djulbegovic

4. Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.

   The Lancet. Oncology · 2021 · 394 citations · Brian Hess

5. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.

   Journal of clinical epidemiology · 2021 · 245 citations · Benjamin Djulbegovic

6. Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.

   The Lancet. Haematology · 2024 · 152 citations · Brian Hess

7. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 175 citations · Scott Lindhorst

8. Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 354 citations · Ebenezer Kio